Abiopharma

News list

📋 Elizabeth Buse (Director) plans to sell 1K shares of F5, Inc. (at $390.77 each, total $391K) Filed: Jun 10, 2026 | ID: 000360

Full text

News bot June 10, 2026, 9:55 p.m.
📋 Form 144 Filing: Elizabeth Buse

Company: F5, Inc.

Filing Date: 2026-06-10

Relationship: Director
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 1,000
- Price per Share: $390.77
- Total Value: $390,770.00
- Planned Sale Date: 2026-06-10
- Broker: Goldman Sachs & Co. LLC
- Exchange: NASD
Additional Information:
- SEC File Number: 000-26041
- Issuer Contact Phone: 1-206-272-5555
- Issuer Address: 801 5th Ave, Seattle, WA, 98104
- Broker Address: 200 West Street, New York, NY, 10282
- Shares Outstanding: 56419247.0
- Number of Securities to be Sold: 1
- Signature: Goldman Sachs & Co. LLC on behalf of Elizabeth Buse